170 related articles for article (PubMed ID: 35145910)
21. Whole-Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer.
Fasmer KE; Hodneland E; Dybvik JA; Wagner-Larsen K; Trovik J; Salvesen Ø; Krakstad C; Haldorsen IHS
J Magn Reson Imaging; 2021 Mar; 53(3):928-937. PubMed ID: 33200420
[TBL] [Abstract][Full Text] [Related]
22. Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
Xin W; Rixin S; Linrui L; Zhihui Q; Long L; Yu Z
Comput Biol Med; 2024 Jul; 177():108593. PubMed ID: 38801795
[TBL] [Abstract][Full Text] [Related]
23. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy.
Yang Y; Zou X; Zhou W; Yuan G; Hu D; Kuang D; Shen Y; Xie Q; Zhang Q; Hu X; Li Z
J Magn Reson Imaging; 2022 Sep; 56(3):739-751. PubMed ID: 35049076
[TBL] [Abstract][Full Text] [Related]
24. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
25. Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer.
Park H; Lim Y; Ko ES; Cho HH; Lee JE; Han BK; Ko EY; Choi JS; Park KW
Clin Cancer Res; 2018 Oct; 24(19):4705-4714. PubMed ID: 29914892
[No Abstract] [Full Text] [Related]
26. Evaluation of Lymph Node Metastasis in Advanced Gastric Cancer Using Magnetic Resonance Imaging-Based Radiomics.
Chen W; Wang S; Dong D; Gao X; Zhou K; Li J; Lv B; Li H; Wu X; Fang M; Tian J; Xu M
Front Oncol; 2019; 9():1265. PubMed ID: 31824847
[No Abstract] [Full Text] [Related]
27. MRI-Based Radiomic Signature as a Prognostic Biomarker for HER2-Positive Invasive Breast Cancer Treated with NAC.
Li Q; Xiao Q; Li J; Duan S; Wang H; Gu Y
Cancer Manag Res; 2020; 12():10603-10613. PubMed ID: 33149669
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of multiparametric MRI-based radiomics model: Potential role for chemotherapeutic benefits in locally advanced rectal cancer.
Cui Y; Yang W; Ren J; Li D; Du X; Zhang J; Yang X
Radiother Oncol; 2021 Jan; 154():161-169. PubMed ID: 32976874
[TBL] [Abstract][Full Text] [Related]
29. Prediction by a multiparametric magnetic resonance imaging-based radiomics signature model of disease-free survival in patients with rectal cancer treated by surgery.
Mao J; Ye W; Ma W; Liu J; Zhong W; Yuan H; Li T; Guan L; Wu D
Front Oncol; 2024; 14():1255438. PubMed ID: 38454930
[TBL] [Abstract][Full Text] [Related]
30. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
[TBL] [Abstract][Full Text] [Related]
31. Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy.
Zhang X; Zhang Q; Guo J; Zhao J; Xie L; Zhang J; An J; Yu X; Zhao X
Eur J Radiol; 2022 May; 150():110272. PubMed ID: 35334244
[TBL] [Abstract][Full Text] [Related]
32. Radiomics Features at Multiparametric MRI Predict Disease-Free Survival in Patients With Locally Advanced Rectal Cancer.
Cui Y; Wang G; Ren J; Hou L; Li D; Wen Q; Xi Y; Yang X
Acad Radiol; 2022 Aug; 29(8):e128-e138. PubMed ID: 34961658
[TBL] [Abstract][Full Text] [Related]
33. Radiomic signature-based nomogram to predict disease-free survival in stage II and III colon cancer.
Yao X; Sun C; Xiong F; Zhang X; Cheng J; Wang C; Ye Y; Hong N; Wang L; Liu Z; Meng X; Wang Y; Tian J
Eur J Radiol; 2020 Oct; 131():109205. PubMed ID: 32871292
[TBL] [Abstract][Full Text] [Related]
34. Establishment and validation of novel MRI radiomic feature-based prognostic models to predict progression-free survival in locally advanced rectal cancer.
Xie F; Zhao Q; Li S; Wu S; Li J; Li H; Chen S; Jiang W; Dong A; Wu L; Liu L; Huang H; Xu S; Shao Y; Liu L; Li L; Cai P
Front Oncol; 2022; 12():901287. PubMed ID: 36408187
[TBL] [Abstract][Full Text] [Related]
35. Predicting the risk of distant metastasis in patients with locally advanced rectal cancer using model based on pre-treatment T2WI-based radiomic features plus postoperative pathological stage.
Wang C; Chen J; Zheng N; Zheng K; Zhou L; Zhang Q; Zhang W
Front Oncol; 2023; 13():1109588. PubMed ID: 37746305
[TBL] [Abstract][Full Text] [Related]
36. MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Corti A; De Cecco L; Cavalieri S; Lenoci D; Pistore F; Calareso G; Mattavelli D; de Graaf P; Leemans CR; Brakenhoff RH; Ravanelli M; Poli T; Licitra L; Corino V; Mainardi L
Biomark Res; 2023 Jul; 11(1):69. PubMed ID: 37455307
[TBL] [Abstract][Full Text] [Related]
37. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
[TBL] [Abstract][Full Text] [Related]
38. Development of a combined model incorporating clinical characteristics and magnetic resonance imaging features to enhance the predictive value of a prognostic model for locally advanced cervical cancer.
Lin C; Yang F; Guo B; Xiao N; Liao D; Liu P; Jiang Y; Li J; Ni X
Front Oncol; 2023; 13():1284493. PubMed ID: 38074674
[TBL] [Abstract][Full Text] [Related]
39. A Computed Tomography-Based Radiomic Prognostic Marker of Advanced High-Grade Serous Ovarian Cancer Recurrence: A Multicenter Study.
Wei W; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wang S; Wang M; Guo Y; Tian J
Front Oncol; 2019; 9():255. PubMed ID: 31024855
[No Abstract] [Full Text] [Related]
40. Preoperative computed tomography-guided disease-free survival prediction in gastric cancer: a multicenter radiomics study.
Wang S; Feng C; Dong D; Li H; Zhou J; Ye Y; Liu Z; Tian J; Wang Y
Med Phys; 2020 Oct; 47(10):4862-4871. PubMed ID: 32592224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
